On-demand webcast of expert faculty presentation on current safety evidence and best practices for managing toxicities related to CAR T-cell therapy when treating certain hematologic malignancies like chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://clinicaloptions.com/activities/oncology/car-t-cell-therapy-safety-evidence/25272-52480/info
- Start Date: 2024-09-26 05:00:00
- End Date: 2024-09-26 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 32500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest